The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
about
An evaluation of sharp cut cyclones for sampling diesel particulate matter aerosol in the presence of respirable dustVancomycin and nephrotoxicity: just another myth?High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis.High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis.Ceftaroline in complicated skin and skin-structure infections.Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model.Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.Tissue penetration of antifungal agents.The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristicsLinezolid, the first oxazolidinone antibacterial agent.Pneumonia in frail older patients: an up to date.Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy.Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.Subtherapeutic linezolid concentrations in a patient with morbid obesity and methicillin-resistant Staphylococcus aureus pneumonia: case report and review of the literature.Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence?Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance.Daptomycin and Its Immunomodulatory Effect: Consequences for Antibiotic Treatment of Methicillin-Resistant Staphylococcus aureus Wound Infections after Heart Surgery.MRSA in Croatia: prevalence and management.Optimization of linezolid treatment regimens for Gram-positive bacterial infections based on pharmacokinetic/pharmacodynamic analysis.Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-Abdominal Abscess Model.The Promise of Molecular Imaging in the Study and Treatment of Infectious Diseases.Vancomycin AUC24 /MIC Ratio in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia.Risk factors associated with high linezolid trough plasma concentrations.Phenotypic Modifications in Staphylococcus aureus Cells Exposed to High Concentrations of Vancomycin and Teicoplanin.Clinical pharmacological approach for balancing the use of daptomycin and linezolid in comparison with that of vancomycin in the treatment of MRSA-related infections.Rising Methicillin-Resistant Staphylococcus aureus Infections in Ear, Nose, and Throat Diseases.In vitro activity of human-simulated epithelial lining fluid exposures of ceftaroline, ceftriaxone, and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus.Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens.Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-lactamase Inhibitor, Dosed in Combination with Imipenem/Cilastatin in Healthy Subjects.Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds.
P2860
Q23912279-6029D606-048E-41B0-89DF-B6E5B5E48B34Q30409849-BF146A73-EA45-4300-9410-7C5A2C19D54AQ33407349-DB1D13F6-690A-4775-B603-62D4D32C45AEQ34290110-2583C090-F859-4927-93DC-E64AE6C597BBQ35123536-A7BF6A60-9235-4F48-A468-0D2CDBA01317Q35715381-141C3187-CE95-493D-AE45-0C04BF671F98Q35941253-A6C84727-3B35-47A8-BFE8-C2F19D319A65Q35959546-80EE73DE-A0D0-417C-82D3-56B1EC4B98D2Q37544911-9EB594D5-83E0-4FF9-93DE-B148B247BE49Q37712989-720739C3-BDA1-4E71-8FBE-012AA659EF76Q37857331-B160533C-C187-426F-BAB0-B0D6C52D5985Q38017909-BD630A04-8177-409A-BF6C-9960E75C77DDQ38018983-E8C5A844-0B17-4764-8958-B98EB870904EQ38066654-879B7D27-F5CC-4C9C-A711-A53AD984CBA3Q38106836-FA9641ED-055C-4BE0-AE38-AD4F72864814Q38110140-6762979E-5DEF-43E5-812A-866AE12789D8Q38170557-FEDAF11A-3C25-49D0-BF0C-C7B8720EA859Q38198019-4CD3206C-42F3-4680-A2E5-3DF548E6CADEQ38631043-96862691-00EA-4E98-B637-7600773B62FDQ38786623-F20675B5-51E5-4543-A4D7-0E16586B9D00Q40121744-35C054F3-5B80-42AA-9689-91B166B3F180Q40347718-B6992484-94BE-4AA5-95FC-547F7EF0DD5DQ40394687-D58EC56A-6F10-412F-ABE0-B7D427D586DEQ40683242-364A8499-88DC-4A39-9780-3005A3451A54Q40809099-8F677ECC-FC8A-4AF3-953F-007DE919FDEEQ40845477-5A1C68B5-8BA6-438C-A191-46ACC1E0813CQ41644764-01DF0C21-F56B-4C23-BBAD-BCC851B9657DQ41713696-9C3EFD0E-FA04-46E1-A034-E4359CE7C09EQ44364364-45A7937E-03C8-4400-A350-9E60B8012DD2Q46255695-243B3F9D-8967-4EEE-83A6-4339F0070910Q47195583-E8084216-3DFE-4602-821C-28DCDA65F6ECQ52592947-1A227D94-54D4-48EB-9645-C7E8F543F295
P2860
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The importance of tissue penet ...... eus: vancomycin and linezolid.
@ast
The importance of tissue penet ...... eus: vancomycin and linezolid.
@en
The importance of tissue penet ...... eus: vancomycin and linezolid.
@nl
type
label
The importance of tissue penet ...... eus: vancomycin and linezolid.
@ast
The importance of tissue penet ...... eus: vancomycin and linezolid.
@en
The importance of tissue penet ...... eus: vancomycin and linezolid.
@nl
prefLabel
The importance of tissue penet ...... eus: vancomycin and linezolid.
@ast
The importance of tissue penet ...... eus: vancomycin and linezolid.
@en
The importance of tissue penet ...... eus: vancomycin and linezolid.
@nl
P1476
The importance of tissue penet ...... eus: vancomycin and linezolid.
@en
P2093
Elizabeth M Wells
Gary E Stein
P304
P356
10.1185/03007990903512057
P407
P577
2010-03-01T00:00:00Z